Display options
Share it on

HeartRhythm Case Rep. 2017 Aug 24;3(10):470-474. doi: 10.1016/j.hrcr.2017.07.005. eCollection 2017 Oct.

Oral quinine sulfate for the treatment of electrical storm and prevention of recurrent shocks in Brugada syndrome after failed cilostazol therapy.

HeartRhythm case reports

Jayaprakash Shenthar, Siva Sankara Chakali, Debashish Acharya, Javed Parvez, Bharatraj Banavalikar

Affiliations

  1. Electrophysiology Unit, Department of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, India.

PMID: 29062700 PMCID: PMC5643860 DOI: 10.1016/j.hrcr.2017.07.005

[No abstract available.]

Keywords: Antiarrhythmic drugs; Brugada syndrome; Cilostazol; Electrical storm; Quinidine; Quinine sulfate; Recurrent ICD shocks

References

  1. Circulation. 2004 Sep 28;110(13):1731-7 - PubMed
  2. Int J Mol Sci. 2016 Sep 28;17(10):null - PubMed
  3. J Biol Chem. 2009 Jul 3;284(27):17968-74 - PubMed
  4. J Antimicrob Chemother. 2012 Oct;67(10):2501-5 - PubMed
  5. J Am Coll Cardiol. 2013 Jun 11;61(23):2383-7 - PubMed
  6. Heart Rhythm. 2012 Dec;9(12):1995-2000 - PubMed
  7. J Cardiovasc Electrophysiol. 2011 May;22(5):594-7 - PubMed
  8. Heart Rhythm. 2007 Jun;4(6):701-2 - PubMed
  9. Arch Int Pharmacodyn Ther. 1977 May;227(1):57-68 - PubMed
  10. Heart Rhythm. 2013 Dec;10(12):1932-63 - PubMed
  11. Heart Rhythm. 2007 Jun;4(6):695-700 - PubMed
  12. J Cardiovasc Electrophysiol. 2006 Feb;17(2):210-2 - PubMed
  13. Circulation. 1995 Nov 15;92(10):2944-50 - PubMed
  14. J Cardiovasc Electrophysiol. 2007 Feb;18(2):234-40 - PubMed
  15. J Cardiovasc Electrophysiol. 2003 May;14(5):455-7 - PubMed

Publication Types